In an infant with SOS1–Noonan syndrome and pulmonary lymphangiectasia and pleural effusions requiring invasive ventilation, trametinib treatment resulted in resolution of the effusions within 1 week and transition to room air after 3 weeks (140). Here, SOS1 is linked to Noonan syndrome.